Guides
Evergreen peptide explainers and research context.
Use the guide library when you need the framework around a fact sheet: safety, FDA status, clinical-trial reading, terminology, and major research milestones.
What are peptides?
A plain-English primer on peptide basics and why context matters.
Read guidePeptide safety
The sitewide safety frame for risks, unknowns, and prohibited guidance.
Read guideClinical trials explained
How to read trial phases, endpoints, registries, and early results.
Read guideFDA-approved peptide medicines
A guide to product-specific approval rather than broad class claims.
Read guideResearch updates
Elamipretide confirmatory trial appears after accelerated approvalWhy the 4TAZPower trial matters for Forzinity's narrow Barth syndrome approval.FDA approves tirzepatide for obstructive sleep apnea in adults with obesityWhat the Zepbound approval covers, what supported it, and what it does not mean.Retatrutide Phase 3 program reports top-line resultsWhat company-reported Phase 3 results do and do not mean while retatrutide remains investigational.